MedPath

Ongoing Registry of Treatment of Chronic Venous Diseases

Recruiting
Conditions
Varicose Veins of Lower Limb
Registration Number
NCT03035747
Lead Sponsor
Medalp Private Surgery Clinic
Brief Summary

Ongoing registration of patients with varicose veins disease treated by means of conventional surgery, endovenous thermal ablations, sclerotherapy, non-tumescent non-thermal methods

Detailed Description

Data of patients treated in different Russian medical centers are entered in a prospective digital database, and continuously updated.

There is planned to conduct prospective randomized, cohort and observational studies on the site of register

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
5000
Inclusion Criteria
  • Varicose veins with any source of pathological reflux, C2 - C6 according to the CEAP classification
Exclusion Criteria
  • no exclusion criteria

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in patency target veins assessed by duplex ultrasonography in different follow up periods after conventional surgery, endovenous thermal ablations, sclerotherapy or non-tumescent non-thermal methodsBaseline, 3 - 6, 12 months post-intervention
Secondary Outcome Measures
NameTimeMethod
Change in Venous Clinical Severity Score (VCSS) (optional)Baseline, 3 and 12 months post-intervention

The VCSS is a validated scoring system for assessing signs, symptoms and complaints of venous disease.

Change in Quality of Life (QoL), assessed by Short form (SF)-36 health survey (optional)Baseline, 3 and 12 months post-intervention

The SF-36 is a generic QoL questionnaire.

Change in Quality of Life (QoL), assessed by Aberdeen Varicose Vein Questionnaire (AVVQ) (optional)Baseline, 3 and 12 months post-intervention

The AVVQ is a disease-specific QoL questionnaire aimed at venous disease.

Trial Locations

Locations (1)

Medalp private surgery clinic

🇷🇺

Saint Petersburg, Russian Federation

© Copyright 2025. All Rights Reserved by MedPath